Join us for an in depth look at how biomodal’s 6-base sequencing technology is advancing gastrointestinal cancer and precancer biomarker discovery.
Dr. Stephen J. Meltzer, Professor of Gastroenterology in the Departments of Medicine and Oncology at The Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center, will share Johns Hopkins’ experience applying biomodal’s 6-base technology to GI cancer and precancer research.
Mark Cosugar, Associate Director of Scientific Affairs at biomodal, will also join to explore how researchers can gain a more complete understanding of genetics and epigenetics using biomodal’s duet multiomics solution.
biomodal will also introduce the newly launched duet mosaic™ family, new workflows for cfDNA and liquid biopsy research that combine genetic, epigenetic, and fragmentomic information from the same molecules, including short, damaged fragments other workflows may miss.
Please register your in person attendance HERE.
Doors open at 11:45 AM with lunch served, followed by the talk at 12:00 PM.
Johns Hopkins Integrated Genomics Center
Turner East Room
720 Rutland Avenue
Baltimore, MD
Unable to join in person? Join us via Zoom. Please register here.
